Clinical Trial News, page-12

Australia seems set to launch a 'National Clinical Trials Front Door'.

This is good news for Cryosite which manages hundreds of clinical trials from its biobank and cold chain logistics operation at South
Granville, NSW.

The streamlined 'front door' concept is being promoted by the Australian Commission on Safety and Quality in Health Care and by AusBiotech.

AusBiotech has been publicly supportive of the concept of a national front door since it was mooted more than two years ago, through national speaking opportunities, formal submissions, and through its ongoing discussions with Ministers and departmental staff.

Federal Health Minister Greg Hunt has previously acknowledged the front door concept as a “golden” opportunity for Australian clinical trials.

The proposed national, interconnected, rapid and streamlined approvals system will:

• include a cross-jurisdictional ethics and governance approvals platform that incorporates key application, notification and approval systems;
• incorporate the Clinical Trials Notification and Clinical Trials Approval schemes administered by the Therapeutic Goods Administration;
• include an embedded and automated next-generation national clinical trials registry;
• provide sophisticated monitoring and reporting functionality for different users.

Idea: Cryosite could seize an opportunity to to boost its low industry profile by publicly supporting this latest major clinical trial initiative. Alas, the group is silent...as per usual.